ID ACACA_SHEEP Reviewed; 2346 AA. AC Q28559; O62847; Q6KEV5; DT 15-JUL-1998, integrated into UniProtKB/Swiss-Prot. DT 01-NOV-1996, sequence version 1. DT 24-JAN-2024, entry version 142. DE RecName: Full=Acetyl-CoA carboxylase 1 {ECO:0000250|UniProtKB:Q13085}; DE Short=ACC1; DE EC=6.4.1.2 {ECO:0000250|UniProtKB:Q13085}; DE AltName: Full=ACC-alpha; GN Name=ACACA {ECO:0000250|UniProtKB:Q13085}; Synonyms=ACAC; OS Ovis aries (Sheep). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Laurasiatheria; Artiodactyla; Ruminantia; Pecora; Bovidae; OC Caprinae; Ovis. OX NCBI_TaxID=9940; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). RC STRAIN=Finn-Dorset; TISSUE=Adipose tissue; RX PubMed=7890176; DOI=10.1016/0378-1119(94)00871-o; RA Barber M.C., Travers M.T.; RT "Cloning and characterisation of multiple acetyl-CoA carboxylase RT transcripts in ovine adipose tissue."; RL Gene 154:271-275(1995). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA] OF 1-144 (ISOFORM 2), TISSUE SPECIFICITY, AND RP INDUCTION BY LACTATION. RC STRAIN=Finn-Dorset; TISSUE=Mammary gland; RX PubMed=9639557; DOI=10.1042/bj3330017; RA Barber M.C., Travers M.T.; RT "Elucidation of a promoter activity that directs the expression of acetyl- RT CoA carboxylase alpha with an alternative N-terminus in a tissue-restricted RT fashion."; RL Biochem. J. 333:17-25(1998). RN [3] RP NUCLEOTIDE SEQUENCE [MRNA] OF 1-93 (ISOFORM 3). RC TISSUE=Brain; RX PubMed=15607423; DOI=10.1016/j.ygeno.2004.10.001; RA Travers M.T., Cambot M., Kennedy H.T., Lenoir G.M., Barber M.C., Joulin V.; RT "Asymmetric expression of transcripts derived from the shared promoter RT between the divergently oriented ACACA and TADA2L genes."; RL Genomics 85:71-84(2005). CC -!- FUNCTION: Cytosolic enzyme that catalyzes the carboxylation of acetyl- CC CoA to malonyl-CoA, the first and rate-limiting step of de novo fatty CC acid biosynthesis. This is a 2 steps reaction starting with the ATP- CC dependent carboxylation of the biotin carried by the biotin carboxyl CC carrier (BCC) domain followed by the transfer of the carboxyl group CC from carboxylated biotin to acetyl-CoA. {ECO:0000250|UniProtKB:Q13085}. CC -!- CATALYTIC ACTIVITY: CC Reaction=acetyl-CoA + ATP + hydrogencarbonate = ADP + H(+) + malonyl- CC CoA + phosphate; Xref=Rhea:RHEA:11308, ChEBI:CHEBI:15378, CC ChEBI:CHEBI:17544, ChEBI:CHEBI:30616, ChEBI:CHEBI:43474, CC ChEBI:CHEBI:57288, ChEBI:CHEBI:57384, ChEBI:CHEBI:456216; EC=6.4.1.2; CC Evidence={ECO:0000250|UniProtKB:Q13085}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:11309; CC Evidence={ECO:0000250|UniProtKB:Q13085}; CC -!- COFACTOR: CC Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000255|PROSITE- CC ProRule:PRU00409, ECO:0000255|PROSITE-ProRule:PRU00969}; CC Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000255|PROSITE- CC ProRule:PRU00409, ECO:0000255|PROSITE-ProRule:PRU00969}; CC Note=Binds 2 magnesium or manganese ions per subunit. CC {ECO:0000255|PROSITE-ProRule:PRU00409, ECO:0000255|PROSITE- CC ProRule:PRU00969}; CC -!- COFACTOR: CC Name=biotin; Xref=ChEBI:CHEBI:57586; CC Evidence={ECO:0000250|UniProtKB:Q13085, ECO:0000255|PROSITE- CC ProRule:PRU01066}; CC -!- ACTIVITY REGULATION: Inhibited by phosphorylation (By similarity). CC Citrate promotes oligomerization of the protein into filaments that CC correspond to the most active form of the carboxylase (By similarity). CC {ECO:0000250|UniProtKB:Q13085}. CC -!- PATHWAY: Lipid metabolism; malonyl-CoA biosynthesis; malonyl-CoA from CC acetyl-CoA: step 1/1. {ECO:0000250|UniProtKB:Q13085}. CC -!- SUBUNIT: Monomer, homodimer, and homotetramer. Can form filamentous CC polymers. Interacts in its inactive phosphorylated form with the BRCT CC domains of BRCA1 which prevents ACACA dephosphorylation and inhibits CC lipid synthesis. Interacts with MID1IP1; interaction with MID1IP1 CC promotes oligomerization and increases its activity. CC {ECO:0000250|UniProtKB:Q13085}. CC -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol CC {ECO:0000250|UniProtKB:Q5SWU9}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative promoter usage; Named isoforms=3; CC Name=1; CC IsoId=Q28559-1; Sequence=Displayed; CC Name=2; Synonyms=E5A; CC IsoId=Q28559-2; Sequence=VSP_026102; CC Name=3; CC IsoId=Q28559-3; Sequence=VSP_026103; CC -!- TISSUE SPECIFICITY: [Isoform 2]: Expressed at high levels in mammary CC gland. {ECO:0000269|PubMed:9639557}. CC -!- INDUCTION: [Isoform 2]: Induced in mammary gland during lactation. CC {ECO:0000269|PubMed:9639557}. CC -!- DOMAIN: Consists of an N-terminal biotin carboxylation/carboxylase (BC) CC domain that catalyzes the ATP-dependent transient carboxylation of the CC biotin covalently attached to the central biotinyl-binding/biotin CC carboxyl carrier (BCC) domain. The C-terminal carboxyl transferase (CT) CC domain catalyzes the transfer of the carboxyl group from carboxylated CC biotin to acetyl-CoA to produce malonyl-CoA. CC {ECO:0000250|UniProtKB:Q13085}. CC -!- PTM: Phosphorylation on Ser-1263 is required for interaction with CC BRCA1. {ECO:0000250|UniProtKB:Q13085}. CC -!- PTM: Phosphorylation at Ser-80 by AMPK inactivates enzyme activity. CC {ECO:0000250|UniProtKB:P11497}. CC -!- PTM: The biotin cofactor is covalently attached to the central CC biotinyl-binding domain and is required for the catalytic activity. CC {ECO:0000250|UniProtKB:Q13085}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; X80045; CAA56352.1; -; mRNA. DR EMBL; AJ001056; CAA04506.1; -; mRNA. DR EMBL; AJ564445; CAD92090.1; -; mRNA. DR RefSeq; NP_001009256.1; NM_001009256.1. [Q28559-1] DR AlphaFoldDB; Q28559; -. DR SMR; Q28559; -. DR STRING; 9940.ENSOARP00000000876; -. DR PaxDb; 9940-ENSOARP00000000876; -. DR GeneID; 443186; -. DR KEGG; oas:443186; -. DR CTD; 31; -. DR eggNOG; KOG0368; Eukaryota. DR OrthoDB; 911at2759; -. DR UniPathway; UPA00655; UER00711. DR Proteomes; UP000002356; Unplaced. DR GO; GO:0005829; C:cytosol; ISS:UniProtKB. DR GO; GO:0003989; F:acetyl-CoA carboxylase activity; ISS:UniProtKB. DR GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW. DR GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW. DR GO; GO:0006084; P:acetyl-CoA metabolic process; ISS:UniProtKB. DR GO; GO:0006633; P:fatty acid biosynthetic process; ISS:UniProtKB. DR GO; GO:2001295; P:malonyl-CoA biosynthetic process; IEA:UniProtKB-UniPathway. DR GO; GO:0051289; P:protein homotetramerization; ISS:UniProtKB. DR CDD; cd06850; biotinyl_domain; 1. DR Gene3D; 2.40.50.100; -; 1. DR Gene3D; 3.40.50.20; -; 1. DR Gene3D; 3.30.1490.20; ATP-grasp fold, A domain; 1. DR Gene3D; 3.30.470.20; ATP-grasp fold, B domain; 1. DR Gene3D; 2.40.460.10; Biotin dependent carboxylase carboxyltransferase; 1. DR Gene3D; 3.90.1770.10; PreATP-grasp domain; 1. DR InterPro; IPR049076; ACCA. DR InterPro; IPR049074; ACCA_BT. DR InterPro; IPR034733; AcCoA_carboxyl_beta. DR InterPro; IPR013537; AcCoA_COase_cen. DR InterPro; IPR011761; ATP-grasp. DR InterPro; IPR013815; ATP_grasp_subdomain_1. DR InterPro; IPR005481; BC-like_N. DR InterPro; IPR001882; Biotin_BS. DR InterPro; IPR011764; Biotin_carboxylation_dom. DR InterPro; IPR005482; Biotin_COase_C. DR InterPro; IPR000089; Biotin_lipoyl. DR InterPro; IPR005479; CbamoylP_synth_lsu-like_ATP-bd. DR InterPro; IPR029045; ClpP/crotonase-like_dom_sf. DR InterPro; IPR011763; COA_CT_C. DR InterPro; IPR011762; COA_CT_N. DR InterPro; IPR016185; PreATP-grasp_dom_sf. DR InterPro; IPR011054; Rudment_hybrid_motif. DR InterPro; IPR011053; Single_hybrid_motif. DR PANTHER; PTHR45728:SF5; ACETYL-COA CARBOXYLASE 1; 1. DR PANTHER; PTHR45728; ACETYL-COA CARBOXYLASE, ISOFORM A; 1. DR Pfam; PF08326; ACC_central; 1. DR Pfam; PF21385; ACCA_BT; 1. DR Pfam; PF02785; Biotin_carb_C; 1. DR Pfam; PF00289; Biotin_carb_N; 1. DR Pfam; PF00364; Biotin_lipoyl; 1. DR Pfam; PF01039; Carboxyl_trans; 1. DR Pfam; PF02786; CPSase_L_D2; 1. DR SMART; SM00878; Biotin_carb_C; 1. DR SUPFAM; SSF52096; ClpP/crotonase; 2. DR SUPFAM; SSF56059; Glutathione synthetase ATP-binding domain-like; 1. DR SUPFAM; SSF52440; PreATP-grasp domain; 1. DR SUPFAM; SSF51246; Rudiment single hybrid motif; 1. DR SUPFAM; SSF51230; Single hybrid motif; 1. DR PROSITE; PS50975; ATP_GRASP; 1. DR PROSITE; PS50979; BC; 1. DR PROSITE; PS00188; BIOTIN; 1. DR PROSITE; PS50968; BIOTINYL_LIPOYL; 1. DR PROSITE; PS50989; COA_CT_CTER; 1. DR PROSITE; PS50980; COA_CT_NTER; 1. DR PROSITE; PS00866; CPSASE_1; 1. DR PROSITE; PS00867; CPSASE_2; 1. PE 2: Evidence at transcript level; KW Acetylation; Allosteric enzyme; Alternative promoter usage; ATP-binding; KW Biotin; Cytoplasm; Fatty acid biosynthesis; Fatty acid metabolism; Ligase; KW Lipid biosynthesis; Lipid metabolism; Magnesium; Manganese; Metal-binding; KW Multifunctional enzyme; Nucleotide-binding; Phosphoprotein; KW Reference proteome. FT CHAIN 1..2346 FT /note="Acetyl-CoA carboxylase 1" FT /id="PRO_0000146766" FT DOMAIN 117..618 FT /note="Biotin carboxylation" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00969" FT DOMAIN 275..466 FT /note="ATP-grasp" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00409" FT DOMAIN 745..819 FT /note="Biotinyl-binding" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01066" FT DOMAIN 1576..1914 FT /note="CoA carboxyltransferase N-terminal" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01136" FT DOMAIN 1918..2234 FT /note="CoA carboxyltransferase C-terminal" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01137" FT REGION 1576..2234 FT /note="Carboxyltransferase" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01138" FT ACT_SITE 441 FT /evidence="ECO:0000250" FT BINDING 315..320 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00409" FT BINDING 424 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT /ligand_label="1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00409, FT ECO:0000255|PROSITE-ProRule:PRU00969" FT BINDING 424 FT /ligand="Mn(2+)" FT /ligand_id="ChEBI:CHEBI:29035" FT /ligand_label="1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00409, FT ECO:0000255|PROSITE-ProRule:PRU00969" FT BINDING 437 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT /ligand_label="1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00409, FT ECO:0000255|PROSITE-ProRule:PRU00969" FT BINDING 437 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT /ligand_label="2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00409, FT ECO:0000255|PROSITE-ProRule:PRU00969" FT BINDING 437 FT /ligand="Mn(2+)" FT /ligand_id="ChEBI:CHEBI:29035" FT /ligand_label="1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00409, FT ECO:0000255|PROSITE-ProRule:PRU00969" FT BINDING 437 FT /ligand="Mn(2+)" FT /ligand_id="ChEBI:CHEBI:29035" FT /ligand_label="2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00409, FT ECO:0000255|PROSITE-ProRule:PRU00969" FT BINDING 439 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT /ligand_label="2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00409, FT ECO:0000255|PROSITE-ProRule:PRU00969" FT BINDING 439 FT /ligand="Mn(2+)" FT /ligand_id="ChEBI:CHEBI:29035" FT /ligand_label="2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00409, FT ECO:0000255|PROSITE-ProRule:PRU00969" FT BINDING 1823 FT /ligand="CoA" FT /ligand_id="ChEBI:CHEBI:57287" FT /evidence="ECO:0000250" FT BINDING 2127 FT /ligand="CoA" FT /ligand_id="ChEBI:CHEBI:57287" FT /evidence="ECO:0000250" FT BINDING 2129 FT /ligand="CoA" FT /ligand_id="ChEBI:CHEBI:57287" FT /evidence="ECO:0000250" FT MOD_RES 1 FT /note="N-acetylmethionine" FT /evidence="ECO:0000250|UniProtKB:Q13085" FT MOD_RES 5 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q13085" FT MOD_RES 23 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q13085" FT MOD_RES 25 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q13085" FT MOD_RES 29 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q13085" FT MOD_RES 34 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:P11497" FT MOD_RES 48 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q13085" FT MOD_RES 50 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:P11497" FT MOD_RES 53 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q13085" FT MOD_RES 58 FT /note="Phosphothreonine" FT /evidence="ECO:0000250|UniProtKB:Q5SWU9" FT MOD_RES 78 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:P11497" FT MOD_RES 80 FT /note="Phosphoserine; by AMPK" FT /evidence="ECO:0000250|UniProtKB:Q5SWU9" FT MOD_RES 610 FT /note="Phosphothreonine" FT /evidence="ECO:0000250|UniProtKB:Q13085" FT MOD_RES 786 FT /note="N6-biotinyllysine" FT /evidence="ECO:0000250|UniProtKB:P11497, FT ECO:0000255|PROSITE-ProRule:PRU01066" FT MOD_RES 835 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q13085" FT MOD_RES 1201 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:P11497" FT MOD_RES 1216 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:P11497" FT MOD_RES 1218 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q5SWU9" FT MOD_RES 1227 FT /note="Phosphothreonine" FT /evidence="ECO:0000250|UniProtKB:Q5SWU9" FT MOD_RES 1259 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q5SWU9" FT MOD_RES 1263 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q13085" FT MOD_RES 1273 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q13085" FT MOD_RES 1334 FT /note="N6-acetyllysine" FT /evidence="ECO:0000250|UniProtKB:Q13085" FT MOD_RES 2153 FT /note="Phosphothreonine" FT /evidence="ECO:0000250|UniProtKB:Q13085" FT VAR_SEQ 1..75 FT /note="MGEPSSLAKPLELNQHSRFIIGSVSEDNSEDEISNLVKLDLLEEKEGSLSPA FT SVSSDTLSDLGISSLQDGLALHM -> MEGSAEESKEMRYYMLQ (in isoform FT 2)" FT /evidence="ECO:0000303|PubMed:9639557" FT /id="VSP_026102" FT VAR_SEQ 1 FT /note="M -> MWWSTLMSILRASSFWKWISAQTIRIIRALRARFEGTM (in FT isoform 3)" FT /evidence="ECO:0000303|PubMed:15607423" FT /id="VSP_026103" SQ SEQUENCE 2346 AA; 265251 MW; BCA010ADF6CD24EF CRC64; MGEPSSLAKP LELNQHSRFI IGSVSEDNSE DEISNLVKLD LLEEKEGSLS PASVSSDTLS DLGISSLQDG LALHMRSSMS GLHLVKQGRD RKKIDSQRDF TVASPAEFVT RFGGNKVIEK VLIANNGIAA VKCMRSIRRW SYEMFRNERA IRFVVMVTPE DLKANAEYIK MADHYVPVPG GPNNNNYANV ELILDIARRI PVQAVWAGWG HASENPKLPE LLLKNGIAFM GPPSQAMWAL GDKIASSIVA QTAGIPTLPW SGSGLCVDWH ENDFSKRILN VPQELYEKGY VKDVDDGLKA AEEVGYPVMI KASEGGGGKG IRKVNNADDF PNLFRQVQAE VPGSPIFVMR LAKQSRHLEV QILADQYGNA ISLFGRDCSV QRRHQKIIEE APAAIATPAV FEHMEQCAVK LARMVGYVSA GTVEYLYSQD GSFYFLELNP RLQVEHPCTE MVADVNLPAA QLQIAMGIPL YRIKDIRMMY GVSPWGDAPI DFENSAHVPC PRGHVIAARI TSENPDEGFK PSSGTVQELN FRSNKNVWGY FSVAAAGGLH EFADSQFGHC FSWGENREEA ISNMVVALKE LSIRGDFRTT VEYLIKLLET ESFQLNRIDT GWLDRLIAEK VQAERPDTML GVVCGALHVA DVSLRNSISN FLHSLERGQV LSAHTLLNTV DVELIYEGEK IVLKVTRQSP NSYVVIMNGS CVEVDVHRLS DGGLLLSYDG SSYTTYMKEE VDRYRITIGN KTCVFEKEND PSVLRSPSAG KLIQYIVEDG GHVFAGQCYA EIEVMKMVMT LTAAESGCIH YVKRPGAALD PGCVIAKMQL DNPSKVQQAE LHTGSLPRIQ STALRGEKLH RVFHYVLDNL VNVMNGYCLP DPFFSSRVKD WVEGLMKTLR DPSLPLLELQ DIMTSVSGRI PPNVEKSIKK EMAQYASNIT SVLCQFPSQQ IANILDSHAA TLNRKSEREV FFMNTQSIVQ LVQRYRSGIR GHMKAVVMDL LRQYLRVETQ FQNGHYDKCV FALREENKSD MNTVLNYIFS HAQVTKKNLL VTMLIDQLCG RDPTLTDELL NILTELTQLS KTTNAKVALR ARQVLIASHL PSYELRHNQV ESIFLSAIDM YGHQFCIENL QKLILSETSI FDVLPNFFYH SNQVVRMAAL EVYVRRAYIA YELNSVQHRQ LKDNTCVVEF QFMLPTSHPN RGNIPTLNRM SFSSNLNHYG MTHVASVSDV LLDNAFTPPC QRMGGMVSFR TFEDFVRIFD EVMGCFCDSP PQSPTFPEAG HTSLYDEDKV PRDEPIHILN VAIKTDCDIE DDSLAAMFRE FTQQNKATLV EHGIRRLTFL VAQKDFRKQV NYEVDQRFHR EFPKFFTFRA RDKFEEDRIY RHLEPALAFQ LELNRMRNFD LTAIPCANHK MHLYLGAAKV EVGTEVTDYR FFVRAIIRHS DLVTKEASFE YLQNEGERLL LEAMDELEVA FNNTNVRTDC NHIFLNFVPT VIMDPSKIEE SVRSMVMRYG SRLWKLRVLQ AELKINIRLT PTGKAIPIRL FLTNESGYYL DISLYKEVTD SRTAQIMFQA YGDKQGPLHG MLINTPYVTK DLLQSKRFQA QSLGTTYIYD IPEMFRQSLI KLWESMSSQA FLPPPPLPSD ILTYTELVLD DQGQLVHMNR LPGGNEIGMV AWKMTLKSPE YPDGRDIIVI GNDITYRIGS FGPQEDLLFL RASELARAEG IPRIYVAANS GARIGLAEEI RHMFHVAWVD PEDPYKGYKY LYLTPQDYKR VSALNSVHCE HVEDEGESRY KITDIIGKEE GLGAENLRGS GMIAGESSLA YDEIITISLV TCRAIGIGAY LVRLGQRTIQ VENSHLILTG AGALNKVLGR EVYTSNNQLG GIQIMHNNGV THSTVCDDFE GVFTVLHWLS YMPKSVYSSV PLLNSKDPID RVIEFVPTKA PYDPRWMLAG RPHPTQKGQW LSGFFDYGSF SEIMQPWAQT VVVGRARLGG IPVGVVAVET RTVELSIPAD PANLDSEAKI IQQAGQVWFP DSAFKTYQAI KDFNREGLPL MVFANWRGFS GGMKDMYDQV LKFGAYIVDG LRECSQPVMV YIPPQAELRG GSWVVIDPTI NPRHMEMYAD RESRGSVLEP EGTVEIKFRR KDLVKTMRRV DPVYIHLAER LGTPELSARE RKELESKLKE REEFLLPIYH QVAVQFADLH DTPGRMQEKG VINDILDWKT SRTFFYWRLR RLLLEDLVKK KIHNANPELT DGQIQAMLRR WFVEVEGTVK AYVWDNNKDL VEWLEKQLTE EDGVRSVIEE NIKYISRDYV LKQIRSLVQA NPEVAMDSIV HMTQHISPTQ RAEVVRILST MDSPST //